Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19
Elizabeth R. Mann, Madhvi Menon, Sean Knight, et al.
Science Immunology (2020) Vol. 5, Iss. 51
Open Access | Times Cited: 241

Showing 1-25 of 241 citing articles:

Diverse functional autoantibodies in patients with COVID-19
Eric Y. Wang, Tianyang Mao, Jon Klein, et al.
Nature (2021) Vol. 595, Iss. 7866, pp. 283-288
Open Access | Times Cited: 814
Single-cell multi-omics analysis of the immune response in COVID-19
Emily Stephenson, Gary Reynolds, Rachel A. Botting, et al.
Nature Medicine (2021) Vol. 27, Iss. 5, pp. 904-916
Open Access | Times Cited: 608
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
Erin Bange, Nicholas Han, Paul Wileyto, et al.
Nature Medicine (2021) Vol. 27, Iss. 7, pp. 1280-1289
Open Access | Times Cited: 444
Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease
Laura Bergamaschi, Federica Mescia, Lorinda Turner, et al.
Immunity (2021) Vol. 54, Iss. 6, pp. 1257-1275.e8
Open Access | Times Cited: 302
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
David Ahern, Zhichao Ai, Mark Ainsworth, et al.
Cell (2022) Vol. 185, Iss. 5, pp. 916-938.e58
Open Access | Times Cited: 254
Monocytes and Macrophages in COVID-19
Rainer Knoll, Joachim L. Schultze, Jonas Schulte-Schrepping
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 235
Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19
Ryan S. Thwaites, Ashley Sanchez Sevilla Uruchurtu, Matthew K. Siggins, et al.
Science Immunology (2021) Vol. 6, Iss. 57
Open Access | Times Cited: 214
Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline
James D. Chalmers, Megan Crichton, Pieter Goeminne, et al.
European Respiratory Journal (2021) Vol. 57, Iss. 4, pp. 2100048-2100048
Open Access | Times Cited: 201
COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects
David M. Smadja, Steven J. Mentzer, Michaëla Fontenay, et al.
Angiogenesis (2021) Vol. 24, Iss. 4, pp. 755-788
Open Access | Times Cited: 164
Physical phenotype of blood cells is altered in COVID-19
Markéta Kubánková, Bettina Hohberger, Jakob Hoffmanns, et al.
Biophysical Journal (2021) Vol. 120, Iss. 14, pp. 2838-2847
Open Access | Times Cited: 158
Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid
Michael Heming, Xiaolin Li, Saskia Räuber, et al.
Immunity (2020) Vol. 54, Iss. 1, pp. 164-175.e6
Open Access | Times Cited: 156
COVID-19 therapeutics: Challenges and directions for the future
Philip C. Robinson, David Liew, Helen Tanner, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 15
Open Access | Times Cited: 142
Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease
Bavithra Vijayakumar, Karim Boustani, Patricia P. Ogger, et al.
Immunity (2022) Vol. 55, Iss. 3, pp. 542-556.e5
Open Access | Times Cited: 137
Alterations in T and B cell function persist in convalescent COVID-19 patients
Halima Ali Shuwa, Tovah N. Shaw, Sean Knight, et al.
Med (2021) Vol. 2, Iss. 6, pp. 720-735.e4
Open Access | Times Cited: 136
Nonsteroidal Anti-inflammatory Drugs Dampen the Cytokine and Antibody Response to SARS-CoV-2 Infection
Jennifer Chen, Mia Madel Alfajaro, Ryan D. Chow, et al.
Journal of Virology (2021) Vol. 95, Iss. 7
Open Access | Times Cited: 135
Single-cell RNA sequencing of blood antigen-presenting cells in severe COVID-19 reveals multi-process defects in antiviral immunity
Mélissa Saichi, Maha Zohra Ladjemi, Sarantis Korniotis, et al.
Nature Cell Biology (2021) Vol. 23, Iss. 5, pp. 538-551
Open Access | Times Cited: 134
COVID-19 salivary Raman fingerprint: innovative approach for the detection of current and past SARS-CoV-2 infections
Cristiano Carlomagno, Dario Bertazioli, Alice Gualerzi, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 126
SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection
Carolyn A. Cohen, Athena P. Y. Li, Asmaa Hachim, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 121
Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8+ T cell responses following COVID-19
Anna H.E. Roukens, Cilia R. Pothast, Marion König, et al.
Nature Immunology (2021) Vol. 23, Iss. 1, pp. 23-32
Open Access | Times Cited: 108
Essential Fatty Acids and Their Metabolites in the Pathobiology of Inflammation and Its Resolution
Undurti N. Das
Biomolecules (2021) Vol. 11, Iss. 12, pp. 1873-1873
Open Access | Times Cited: 102
A persistent neutrophil-associated immune signature characterizes post–COVID-19 pulmonary sequelae
Peter M. George, Anna Reed, Sujal R. Desai, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 671
Open Access | Times Cited: 72
Fungal microbiota sustains lasting immune activation of neutrophils and their progenitors in severe COVID-19
Takato Kusakabe, Woan-Yu Lin, Jin‐Gyu Cheong, et al.
Nature Immunology (2023) Vol. 24, Iss. 11, pp. 1879-1889
Open Access | Times Cited: 40
Prior vaccination prevents overactivation of innate immune responses during COVID-19 breakthrough infection
Leslie Chan, Kassandra Pinedo, Mikayla A. Stabile, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 783
Closed Access | Times Cited: 2
Diverse Functional Autoantibodies in Patients with COVID-19
Eric Y. Wang, Tianyang Mao, Jon Klein, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 131
The Potential for Repurposing Anti-TNF as a Therapy for the Treatment of COVID-19
Philip C. Robinson, David Liew, Jean W. Liew, et al.
Med (2020) Vol. 1, Iss. 1, pp. 90-102
Open Access | Times Cited: 119
Page 1 - Next Page

Scroll to top